what to expect when switching from semaglutide to tirzepatide between weight-loss medications Tirzepatide vs. Semaglutide for Weight

People with severe kidney or liver disease may require caution or alternative treatments, and their use should be discussed with healthcare providers

In 2024, oral semaglutide adoption grew by 44%, contributing to 26% of total semaglutide usage

You should notice: Stronger appetite suppression returning Food noise decreasing significantly Possible return of GI side effects for 3 to 5 days after the dose increase Weight loss resuming if it had stalled This is the dose where many people who switched from semaglutide start seeing results that exceed what semaglutide ever produced

P = .005) compared with participants without diabetes